$13.56
+0 (+0%)
At Close: Aug 04, 2026
$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Organon & Co. (NYSE: OGN)
10:43am, Monday, 27'th Apr 2026
NEW YORK, April 27, 2026 (GLOBE NEWSWIRE) -- Class Action Attorney Juan Monteverde with Monteverde & Associates PC (the “M&A Class Action Firm”), has recovered millions of dollars for shareholde
Top insights from the latest market news from Monday, April 27, from The Motley Fool analysts on Team Rule Breakers and Team Hidden Gems.
Organon (OGN) Soars 30.9%: Is Further Upside Left in the Stock?
09:30am, Monday, 27'th Apr 2026
Organon (OGN) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength dow
Stock Futures Subdued by Geopolitical Uncertainty
09:11am, Monday, 27'th Apr 2026
Stock futures are struggling this morning as investors await Magnificent Seven earnings and the Fed meeting
U.S. stock futures fell on Monday, following Friday's mixed close. Futures of the major benchmark indices were lower. This week, investors will be closely watching the Federal Reserve's meeting to gau
OGN Stock Alert: Halper Sadeh LLC is Investigating Whether Organon & Co. is Obtaining a Fair Price for its Shareholders
08:20am, Monday, 27'th Apr 2026
NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating the sale of Organon & Co. (NYSE: OGN) to Sun Pharmaceutical Industries Limited for $14.00 per share.Halper Sa
Organon Stock Soars After Sun Seals Takeover. Why Pharma M&A Is a Hot Play.
05:22am, Monday, 27'th Apr 2026
India's Sun Pharmaceutical Industries agrees to buy the women's health company for $14 a share in an all-cash deal.
Shareholder Alert: Ademi LLP investigates whether Organon & Co. is obtaining a Fair Price for Public Shareholders
02:23am, Monday, 27'th Apr 2026
MILWAUKEE, April 27, 2026 /PRNewswire/ -- Ademi LLP is investigating Organon (NYSE: OGN) for possible breaches of fiduciary duty and other violations of law in its recently announced transaction with
Organon To Be Acquired By Sun Pharma In $11.75B Deal, OGN Stock Spikes Nearly 17% On Robinhood 24-Hour Market
01:57am, Monday, 27'th Apr 2026
Organon and Co. has agreed to be acquired by Sun Pharmaceutical Industries in an all-cash deal valued at $11.75 billion, offering shareholders a 103% premium and marking a major step in Sun Pharma's g
Why is Sun Pharma betting $11.75B on a struggling US drugmaker?
12:19am, Monday, 27'th Apr 2026
In one of the biggest outbound acquisitions ever attempted by an Indian company, Sun Pharmaceutical Industries has decided to buy Organon & Co. for $14 a share in an all-cash deal valued at $11.8 bill
Indian drugmaker Sun Pharma to buy U.S. firm Organon in $11.75 billion deal
10:13pm, Sunday, 26'th Apr 2026
Sun Pharmaceutical Industries will acquire New Jersey-based Organon & Co in an all-cash deal that values the U.S. company at $11.75 billion. Sun Pharmaceutical will buy all outstanding shares of Organ
Sun Pharmaceutical to Acquire Organon Valued at $11.75 Billion
09:16pm, Sunday, 26'th Apr 2026
Sun Pharma has offered to pay $14.00 a share in an all-cash deal.
Sun Pharma to acquire Organon in $11.75 bln all-cash deal
08:01pm, Sunday, 26'th Apr 2026
Sun Pharmaceutical Industries will acquire Organon & Co in an all‑cash deal, valuing the U.S. drugmaker at about $11.75 billion, the companies said in a joint
Sun Pharma signs Definitive Agreement to Acquire Organon
07:51pm, Sunday, 26'th Apr 2026
MUMBAI, India & JERSEY CITY, N.J.--(BUSINESS WIRE)--Sun Pharmaceutical Industries Limited (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715) (together with its subsidiaries and/or asso
Organon & Co. (OGN) is Attracting Investor Attention: Here is What You Should Know
10:02am, Thursday, 23'rd Apr 2026
Zacks.com users have recently been watching Organon (OGN) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Sign In
Buy OGN